US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

INVO Fertility, Inc

1.46

+0.04002.82%

Post-market: 1.43-0.0299-2.05%18:47 EDT

Volume:66.84K

Turnover:95.83K

Market Cap:3.16M

PE:-0.03

High:1.48

Open:1.43

Low:1.40

Close:1.42

Loading ...

Overview Company News Filings

Monash IVF Recovers From Embryo Transfer Mix-Up-Related Slump; Shares Up 15%

MT Newswires Live

Jefferies Sticks to Their Buy Rating for Monash IVF Group Ltd (MVF)

Monash IVF Addresses Embryo Transfer Incident with Enhanced Safeguards

Monash IVF admits to second embryo transfer bungle this year

The Australian Financial Review

INVO Fertility Inc. Releases Pro Forma Financial Statements Following NTI Divestiture

Invo Fertility Inc. Announces Conversion of NTI Preferred Shares into Common Stock as Part of New Agreement

Monash IVF Keeps Bull Despite Guidance Downgrade -- Market Talk

Monash IVF Could Be M&A Target for Bidder With Long-Term View -- Market Talk

Ord Minnett Sticks to Its Buy Rating for Monash IVF Group Ltd (MVF)

Monash IVF Group Ltd (MVF) Receives a Buy from Macquarie

Monash IVF Group Ltd (MVF) was upgraded to a Buy Rating at Morgans

Monash IVF Group Ltd (MVF) Receives a Buy from Bell Potter

INVO Fertility Q1 EPS $(12.53) Down From $(7.55) YoY, Sales $1.64M Beat $1.61M Estimate

Press Release: INVO Fertility Announces First Quarter 2025 Financial Results

Monash IVF downgrades full-year profit outlook

The Australian Financial Review

Monash IVF's Profit Warning Not So Surprising -- Market Talk

Monash IVF Group Revises FY2025 Profit Guidance Amid Challenging Market Conditions

Monash IVF Group Cuts Fiscal 2025 Profit Guidance to About AU$27.5 Million

MT Newswires Live

Invo Fertility Inc. Files Amendment to 10-K Annual Report

INVO Fertility Inc. Announces Delayed Q1 2025 Financial Reporting Due to Intangible Impairment

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/IVF/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVF\",,,,,undefined,":{"symbol":"IVF","market":"US","secType":"STK","nameCN":"INVO Fertility, Inc","latestPrice":1.46,"timestamp":1749672000000,"preClose":1.42,"halted":0,"volume":66842,"hourTrading":{"tag":"盘后","latestPrice":1.4301,"preClose":1.46,"latestTime":"18:47 EDT","volume":1548,"amount":2220.9173028,"timestamp":1749682035515},"delay":0,"floatShares":2011399,"shares":2161131,"eps":-45.658928,"marketStatus":"Post-Mkt","change":0.04,"latestTime":"06-11 19:10:46 EDT","open":1.43,"high":1.48,"low":1.4,"amount":95828.9156144,"amplitude":0.056338,"askPrice":1.49,"askSize":66,"bidPrice":1.32,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-45.658928,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1749686400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.42,"preHourTrading":{"tag":"盘前","latestPrice":1.4488,"preClose":1.42,"latestTime":"09:29 EDT","volume":1763,"amount":2548.8521373,"timestamp":1749648598649},"postHourTrading":{"tag":"盘后","latestPrice":1.4301,"preClose":1.46,"latestTime":"18:47 EDT","volume":1548,"amount":2220.9173028,"timestamp":1749682035515},"volumeRatio":0.550191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IVF\",,,,,undefined,":{"symbol":"IVF","floatShares":2011399,"roa":"--","roe":"--","lyrEps":-15.347407,"volumeRatio":0.550191,"shares":2161131,"dividePrice":0,"high":1.48,"amplitude":0.056338,"preClose":1.42,"low":1.4,"week52Low":1.37,"pbRate":"-0.12","psRate":"0.48","week52High":17.04,"institutionHeld":0,"latestPrice":1.46,"committee":0.847575,"eps":-45.658928,"divideRate":0,"volume":66842,"delay":0,"ttmEps":-45.658928,"open":1.43,"prevYearClose":9.72,"prevWeekClose":1.46,"prevMonthClose":1.69,"prevQuarterClose":2,"fiveDayClose":1.59,"twentyDayClose":1.98,"sixtyDayClose":2.394},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVF\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542137932","title":"Monash IVF Recovers From Embryo Transfer Mix-Up-Related Slump; Shares Up 15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542137932","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542137932?lang=en_us&edition=fundamental","pubTime":"2025-06-11 12:39","pubTimestamp":1749616795,"startTime":"0","endTime":"0","summary":"Monash IVF Group  shares rose nearly 15% in recent Wednesday trade following Tuesday's steep fall after the company disclosed its second embryo transfer error.RBC Capital Markets analyst Craig Wong-Pan said the mistake carries risks of higher reputational damage and possible market share losses, according to a Tuesday report from The Australian.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","XAO.AU","IVF","MVF.AU","BK4082","BK7113","XKO.AU","BK7508"],"gpt_icon":0},{"id":"2542487613","title":"Jefferies Sticks to Their Buy Rating for Monash IVF Group Ltd (MVF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2542487613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542487613?lang=en_us&edition=fundamental","pubTime":"2025-06-10 22:05","pubTimestamp":1749564345,"startTime":"0","endTime":"0","summary":"Jefferies analyst David Stanton maintained a Buy rating on Monash IVF Group Ltd (MVF – Research Report) today and set a price target of A$1.05. The...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-monash-ivf-group-ltd-mvf-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/jefferies-sticks-to-their-buy-rating-for-monash-ivf-group-ltd-mvf-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVF","VFC","MVF"],"gpt_icon":0},{"id":"2542935266","title":"Monash IVF Addresses Embryo Transfer Incident with Enhanced Safeguards","url":"https://stock-news.laohu8.com/highlight/detail?id=2542935266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542935266?lang=en_us&edition=fundamental","pubTime":"2025-06-10 09:27","pubTimestamp":1749518830,"startTime":"0","endTime":"0","summary":"Monash IVF Group Ltd ( ($AU:MVF) ) has provided an announcement. Monash IVF Group Limited announced an incident at its Clayton laboratory where an ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/monash-ivf-addresses-embryo-transfer-incident-with-enhanced-safeguards?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/monash-ivf-addresses-embryo-transfer-incident-with-enhanced-safeguards?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4082","BK4504","IVF","LU1670711040.USD","LU1670711123.USD","LU1670710661.SGD","VFC","BK4585","BK4202","LU1670710588.SGD"],"gpt_icon":0},{"id":"2542363830","title":"Monash IVF admits to second embryo transfer bungle this year","url":"https://stock-news.laohu8.com/highlight/detail?id=2542363830","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542363830?lang=en_us&edition=fundamental","pubTime":"2025-06-10 09:05","pubTimestamp":1749517500,"startTime":"0","endTime":"0","summary":"Monash IVF says it has mistakenly transferred the wrong embryo to a patient in a Melbourne laboratory, the second time in two months that the ASX-listed fertility services has admitted to the same error.Monash IVF shares slumped more than 17 per cent on Tuesday after the company disclosed the issue, taking their slide to almost 50 per cent since the original incident was made public in early April.Loading...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/companies/healthcare-and-fitness/monash-ivf-admits-to-second-embryo-transfer-bungle-this-year-20250610-p5m66f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["BK4082","IVF"],"gpt_icon":0},{"id":"2541898188","title":"INVO Fertility Inc. Releases Pro Forma Financial Statements Following NTI Divestiture","url":"https://stock-news.laohu8.com/highlight/detail?id=2541898188","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541898188?lang=en_us&edition=fundamental","pubTime":"2025-06-07 04:06","pubTimestamp":1749240385,"startTime":"0","endTime":"0","summary":"INVO Fertility Inc. has released its unaudited pro forma financial statements reflecting the divestiture of its majority holdings in NAYA Therapeutics Inc. . The NTI Divestiture, consummated on June 2, 2025, involved the redemption of Series C-1 Non-Voting Convertible Preferred Stock in exchange for shares of Class A Common Stock of NTI. The pro forma financials, which include a consolidated balance sheet as of March 31, 2025, and statements of operations for the three months ended March 31, 2025, and the year ended December 31, 2024, provide insights into INVO's financial condition post-divestiture. The statements are intended for informational purposes and should be read alongside INVO's historical financial reports.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250606:nNDL9cGW8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2539031512","title":"Invo Fertility Inc. Announces Conversion of NTI Preferred Shares into Common Stock as Part of New Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2539031512","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539031512?lang=en_us&edition=fundamental","pubTime":"2025-05-31 05:30","pubTimestamp":1748640650,"startTime":"0","endTime":"0","summary":"Invo Fertility Inc. has announced a strategic financial move involving its holdings in NTI. The company entered into an agreement to exchange 801,196 shares of NTI Class A Common Stock, representing 19.9% of NTI's outstanding common shares, for 6,300 shares of NTI Series A Preferred Stock. These preferred shares have a stated value of $1,000 each and are convertible into NTI Class A Common Stock under specific conditions, such as NTI's listing on a major stock exchange or by the seventh anniversary of issuance. Additionally, NTI issued a secured convertible promissory note amounting to $4,803,175 to Invo Fertility Inc., with an interest rate of 7% per annum and a maturity date set for November 28, 2026. This financial maneuver is expected to enhance Invo's strategic positioning within NTI.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250530:nNDL4H8bBF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2538858481","title":"Monash IVF Keeps Bull Despite Guidance Downgrade -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2538858481","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538858481?lang=en_us&edition=fundamental","pubTime":"2025-05-27 08:58","pubTimestamp":1748307480,"startTime":"0","endTime":"0","summary":"0058 GMT - Monash IVF keeps its bull at Wilsons despite its guidance downgrade. Analyst Shane Storey thinks that the downgrade, which left the company's FY25 underlying profit guidance 9% below the average analyst forecast, is primarily due to softer cycle volumes across the industry. He points out in a note to clients that Monash still managed to maintain market share in the March quarter, which gives him some comfort on its prospects. He is conservative in his forecasts for cycle growth but still thinks that there is considerable upside to the stock at current levels. Wilsons cuts its target price 11% to A$1.25 and stays overweight on the stock, which is down 0.6% at A$0.775. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","MVF.AU"],"gpt_icon":0},{"id":"2537957585","title":"Monash IVF Could Be M&A Target for Bidder With Long-Term View -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2537957585","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537957585?lang=en_us&edition=fundamental","pubTime":"2025-05-22 06:47","pubTimestamp":1747867620,"startTime":"0","endTime":"0","summary":"2247 GMT - Monash IVF's share-price fall following this week's profit warning leaves the company more vulnerable to a bid. Jefferies says reasons for Monash IVF lowering FY 2025 profit guidance to some A$27.5 million likely include the discretionary nature of IVF treatment as well as Monash IVF's exposure to Victoria, a state that is facing economic challenges. \"We do not expect a sudden turnaround in IVF volumes but highlight there may be corporate interest in IVF if an acquirer is willing to take a longer-term view given favorable industry dynamics,\" analyst David Stanton says. Monash IVF's shares are down around 47% over the past 12 months. ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","MVF.AU","IVF","BK7113","BK7508"],"gpt_icon":0},{"id":"2537736226","title":"Ord Minnett Sticks to Its Buy Rating for Monash IVF Group Ltd (MVF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2537736226","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537736226?lang=en_us&edition=fundamental","pubTime":"2025-05-21 09:35","pubTimestamp":1747791343,"startTime":"0","endTime":"0","summary":"In a report released today, Tom Godfrey from Ord Minnett maintained a Buy rating on Monash IVF Group Ltd (MVF – Research Report), with a price targ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-sticks-to-its-buy-rating-for-monash-ivf-group-ltd-mvf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-sticks-to-its-buy-rating-for-monash-ivf-group-ltd-mvf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVF","VFC","MVF"],"gpt_icon":0},{"id":"2537627625","title":"Monash IVF Group Ltd (MVF) Receives a Buy from Macquarie","url":"https://stock-news.laohu8.com/highlight/detail?id=2537627625","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537627625?lang=en_us&edition=fundamental","pubTime":"2025-05-21 08:35","pubTimestamp":1747787723,"startTime":"0","endTime":"0","summary":"In a report released today, Rachael Harwood from Macquarie maintained a Buy rating on Monash IVF Group Ltd (MVF – Research Report), with a price ta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/monash-ivf-group-ltd-mvf-receives-a-buy-from-macquarie-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/monash-ivf-group-ltd-mvf-receives-a-buy-from-macquarie-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1670711040.USD","MVF","LU1670710588.SGD","VFC","BK4504","BK4588","BK4202","IVF","BK4082","LU1670711123.USD","BK4585","LU1670710661.SGD"],"gpt_icon":0},{"id":"2537358624","title":"Monash IVF Group Ltd (MVF) was upgraded to a Buy Rating at Morgans","url":"https://stock-news.laohu8.com/highlight/detail?id=2537358624","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537358624?lang=en_us&edition=fundamental","pubTime":"2025-05-21 07:35","pubTimestamp":1747784120,"startTime":"0","endTime":"0","summary":"Monash IVF Group Ltd (MVF – Research Report) received a Buy rating and a A$1.00 price target from Morgans analyst Emily Porter today. The company’s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/monash-ivf-group-ltd-mvf-was-upgraded-to-a-buy-rating-at-morgans?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/monash-ivf-group-ltd-mvf-was-upgraded-to-a-buy-rating-at-morgans?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVF","VFC","MVF"],"gpt_icon":0},{"id":"2537333624","title":"Monash IVF Group Ltd (MVF) Receives a Buy from Bell Potter","url":"https://stock-news.laohu8.com/highlight/detail?id=2537333624","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537333624?lang=en_us&edition=fundamental","pubTime":"2025-05-21 07:35","pubTimestamp":1747784116,"startTime":"0","endTime":"0","summary":"Bell Potter analyst Martyn Jacobs maintained a Buy rating on Monash IVF Group Ltd (MVF – Research Report) today and set a price target of A$1.15. T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/monash-ivf-group-ltd-mvf-receives-a-buy-from-bell-potter?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/monash-ivf-group-ltd-mvf-receives-a-buy-from-bell-potter?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVF","LU1670711123.USD","MVF","BK4588","BK4585","BK4082","LU1670710588.SGD","BK4504","VFC","BK4202","LU1670711040.USD","LU1670710661.SGD"],"gpt_icon":0},{"id":"2537238846","title":"INVO Fertility Q1 EPS $(12.53) Down From $(7.55) YoY, Sales $1.64M Beat $1.61M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2537238846","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537238846?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:09","pubTimestamp":1747771747,"startTime":"0","endTime":"0","summary":"INVO Fertility (NASDAQ:IVF) reported quarterly losses of $(12.53) per share. This is a 65.96 percent decrease over losses of $(7.55) per share from the same period last year.  The company reported quarterly sales of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45529488/invo-fertility-q1-eps-12-53-down-from-7-55-yoy-sales-1-64m-beat-1-61m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF"],"gpt_icon":0},{"id":"2537623811","title":"Press Release: INVO Fertility Announces First Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2537623811","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537623811?lang=en_us&edition=fundamental","pubTime":"2025-05-21 04:05","pubTimestamp":1747771500,"startTime":"0","endTime":"0","summary":"SARASOTA, Fla., May 20, 2025  -- INVO Fertility, Inc.  , a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses and technologies, today announced first quarter 2025 financial results.-- Revenue was $1,637,185, an increase of 4% compared to $1,576,286.-- Consolidated clinic revenue from the Company's INVO Center in Atlanta,Georgia, and fertility clinic in Madison, Wisconsin, increased 5% to. -- Revenue from all clinics, including both consolidated and equity method. clinics, was $1,943,763, an increase of 4% compared to $1,869,513.-- Net loss was $ million compared to $(1.6) million. Included in net. loss was a non-cash impairment charge of $14.6 million on the assets. related to the acquisition of NAYA Therapeutics, Inc. , a $1.3. million operating loss related to NAYA TX, and costs associated with the. impairment and operating losses from NAYA TX, or corr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","BK4082","BK4022","IVF"],"gpt_icon":0},{"id":"2536696394","title":"Monash IVF downgrades full-year profit outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2536696394","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536696394?lang=en_us&edition=fundamental","pubTime":"2025-05-20 16:06","pubTimestamp":1747728360,"startTime":"0","endTime":"0","summary":"Embattled fertility group Monash IVF has downgraded its full-year earnings guidance after operating conditions deteriorated last month but denied this was linked to a major mistake at one of its clini","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/companies/healthcare-and-fitness/monash-ivf-downgrades-full-year-profit-outlook-20250520-p5m0si","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["IVF"],"gpt_icon":0},{"id":"2536651810","title":"Monash IVF's Profit Warning Not So Surprising -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2536651810","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536651810?lang=en_us&edition=fundamental","pubTime":"2025-05-20 08:33","pubTimestamp":1747701180,"startTime":"0","endTime":"0","summary":"0033 GMT - In vitro fertilization specialist Monash IVF's profit warning today didn't surprise Ord Minnett much. Monash IVF today said it now expects an FY 2025 underlying net profit of some A$27.5 million, down from guidance of A$30.0 million-A$31.0 million given to investors in late February. Analyst Tom Godfrey said Monash IVF had signaled a subdued outlook at its 1H result and recent Medicare data have been weak. \"While we expect medium-term consensus downgrades and a weaker share price today, we note that the updated FY 2025 P/E is 12x suggesting some of this had already been priced in,\" Ord Minnett says. Monash IVF falls 11% to A$0.76. ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7113","IVF","BK4082","BK7508","MVF.AU"],"gpt_icon":0},{"id":"2536065608","title":"Monash IVF Group Revises FY2025 Profit Guidance Amid Challenging Market Conditions","url":"https://stock-news.laohu8.com/highlight/detail?id=2536065608","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536065608?lang=en_us&edition=fundamental","pubTime":"2025-05-20 07:48","pubTimestamp":1747698500,"startTime":"0","endTime":"0","summary":"Monash IVF Group Ltd ( ($AU:MVF) ) has provided an update. Monash IVF Group Limited has revised its profit guidance for the fiscal year ending June...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/monash-ivf-group-revises-fy2025-profit-guidance-amid-challenging-market-conditions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/monash-ivf-group-revises-fy2025-profit-guidance-amid-challenging-market-conditions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VFC","BK4202","BK4082","BK4588","IVF","LU1670711123.USD","LU1670710588.SGD","BK4585","BK4504","LU1670710661.SGD","LU1670711040.USD"],"gpt_icon":0},{"id":"2536656692","title":"Monash IVF Group Cuts Fiscal 2025 Profit Guidance to About AU$27.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2536656692","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536656692?lang=en_us&edition=fundamental","pubTime":"2025-05-20 07:47","pubTimestamp":1747698426,"startTime":"0","endTime":"0","summary":"Monash IVF Group  now expects fiscal 2025 underlying group net profit after tax to be about AU$27.5 million, compared with its previous guidance of between AU$30 million and AU$31 million, according to a Tuesday Australian bourse filing.The company said its revised guidance reflects its assessment of softer market and operating conditions that worsened in April across all of its geographic markets.The company added that its new Australian vitro fertilization  patient resgistration, returning IVF patients for stimulated cycles, and other indicators are currently consistent with the months before it dsiclosed the Brisbane incident, where an embryo was mistakenly implanted into the wrong patient at its Brisbane clinic, resulting in the birth of a child.The company will disclose its fiscal 2025 results on Aug. 22.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK4504","XAO.AU","VFC","LU1670710588.SGD","LU1670711123.USD","MVF.AU","BK7113","BK4082","BK4585","BK4202","LU1670711040.USD","XKO.AU","XJO.AU","BK4588","LU1670710661.SGD","IVF"],"gpt_icon":0},{"id":"2536630943","title":"Invo Fertility Inc. Files Amendment to 10-K Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2536630943","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536630943?lang=en_us&edition=fundamental","pubTime":"2025-05-20 04:47","pubTimestamp":1747687650,"startTime":"0","endTime":"0","summary":"Invo Fertility Inc. filed an amendment to the 10-K annual report for the fiscal year ended December 31, 2024. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250519:nNDL1X5w7z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0},{"id":"2535870550","title":"INVO Fertility Inc. Announces Delayed Q1 2025 Financial Reporting Due to Intangible Impairment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535870550","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535870550?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:06","pubTimestamp":1747339603,"startTime":"0","endTime":"0","summary":"INVO Fertility, Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the fiscal period ended March 31, 2025. The company cited the need for additional time to finalize its financial statements as the reason for the delay. INVO Fertility expects to submit the report within a five-day extension period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 15, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL7s3v1R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVF","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-20","symbol":"IVF","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747713600000,"reportTimeType":"post","actualEps":-12.53},{"market":"US","date":"2025-04-30","symbol":"IVF","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745985600000,"reportTimeType":"pre","actualEps":-9.04}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVF\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IVF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1737691200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IVF\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IVF","date":"2025-06-10","current":-0.131041,"percent":0.37931,"low":-0.159634,"twenty":-0.145132,"median":-0.105784,"eighty":-0.084986,"high":-0.047608,"avg":-0.111731,"sd":0.031562,"marketCap":3263307},"quantilePoints":[{"date":"2025-05-02","current":-0.084268,"twenty":-0.093412,"median":-0.081803,"eighty":-0.076469,"marketCap":1252187},{"date":"2025-05-09","current":-0.096819,"twenty":-0.099867,"median":-0.085165,"eighty":-0.080144,"marketCap":1438683},{"date":"2025-05-16","current":-0.087854,"twenty":-0.096012,"median":-0.089646,"eighty":-0.082834,"marketCap":1305471},{"date":"2025-05-23","current":-0.047608,"twenty":-0.105515,"median":-0.090543,"eighty":-0.080144,"marketCap":1185581},{"date":"2025-05-30","current":-0.146711,"twenty":-0.145427,"median":-0.093681,"eighty":-0.082116,"marketCap":3653522},{"date":"2025-06-06","current":-0.128588,"twenty":-0.145427,"median":-0.100629,"eighty":-0.084627,"marketCap":3202205},{"date":"2025-06-10","current":-0.131041,"twenty":-0.145132,"median":-0.105784,"eighty":-0.084986,"marketCap":3263307}],"updateTime":1749683446140}}}